GYRE vs XPEV · rev $53.5M vs rev $895.7M
Gyre Therapeutics Inc. (GYRE) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
GYRE currently screens at market cap $589.9M. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the GYRE and XPEV stock pages for the full models.
Not investment advice.